Last reviewed · How we verify
Malignant tumor of ovary
Approved treatments
- Gemcitabin · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Camtobell · Chong Kun Dang
- Yondelis · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Yondelis · Janssen Prods
Yondelis works by binding to DNA and causing interstrand crosslinks, thereby inhibiting cancer cell growth. - Gemzar · Accord Hlthcare
Gemcitabine kills cells during DNA synthesis and blocks G1/S-phase progression. - Paraplatin · MYLAN SEIYAKU Ltd
Carboplatin produces predominantly interstrand DNA cross-links in a cell-cycle nonspecific manner. - Platinol-Aq · Pfizer
- Zejula · GSK
Zejula works by blocking the action of an enzyme called PARP, which helps repair damaged DNA in cancer cells. - Nogitecan · Novartis
Topotecan is a topoisomerase inhibitor that prevents DNA re-ligation, causing double-strand DNA damage. - Taxol · Pfizer
Taxol works by binding to tubulin and preventing the formation of microtubules, which are essential for cell division. - alkeran · French Innovative Leukemia Organisation
- adriacin · Chipscreen Biosciences, Ltd.
- Hydroxydaunorubicin · University of Colorado, Denver
- Hycamtin · North Eastern German Society of Gynaecological Oncology
- tretamine
- Lynparza · University of Texas Southwestern Medical Center
- Lynparza · AstraZeneca
Lynparza blocks the repair of DNA damage in cancer cells by inhibiting the enzyme PARP. - Gemzar · Accord Hlthcare
Gemzar works by mimicking a building block of DNA, tricking cancer cells into incorporating it into their DNA and then stopping the replication process. - Taxol · Pfizer
- Hexalen · Eisai
- Liposomal Doxorubicin · Pfizer
- Taxol · Pfizer
- Alkeran · Apotex
- Doxorubicin Hydrochloride · Pfizer
Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, an enzyme essential for DNA replication and cell division. - Hydroxycarbamide · University of Birmingham
- Hydroxydaunomycin · Weill Medical College of Cornell University
- Siklos · Theravia
- Abraxane · The First Affiliated Hospital with Nanjing Medical University
- Adriamycin · Johann Wolfgang Goethe University Hospital
- Paraplatin · ARCAGY/ GINECO GROUP
- Taxol · M.D. Anderson Cancer Center
- Xromi · Nova Laboratories Limited
- Hydroxycarbamid · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Clinical guidelines
- FDA label — 1L
Carboplatin injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents, such as cyclophosphamide. - FDA label — 2L
Carboplatin injection is indicated for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with cisplatin. - FDA label — 2L
Gemcitabine Injection in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy. - FDA label — 2L
Gemcitabine Injection in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Malignant tumor of ovary patent landscape — cliff calendar, originator estates, attackable patents
- Malignant tumor of ovary treatment landscape brief
- Malignant tumor of ovary treatment updates RSS
Frequently asked questions about Malignant tumor of ovary
What drugs treat Malignant tumor of ovary?
Tracked treatments include Gemcitabin, Camtobell, Yondelis, Gemzar, Paraplatin, Platinol-Aq, Zejula, Nogitecan.
What is the treatment for Malignant tumor of ovary?
Standard treatment for Malignant tumor of ovary includes Gemcitabin, Camtobell, Yondelis, Gemzar, Paraplatin. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Malignant tumor of ovary?
FDA label publishes guidelines for Malignant tumor of ovary. 4 guideline references tracked.
Related
- Treatment landscape: Malignant tumor of ovary patent cliff · Malignant tumor of ovary CI report
- Treatment: Gemcitabin · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Treatment: Camtobell · Chong Kun Dang
- Treatment: Yondelis · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Treatment: Yondelis · Janssen Prods
- Treatment: Gemzar · Accord Hlthcare
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing